298 related articles for article (PubMed ID: 26905655)
1. Antibody Production in Plants and Green Algae.
Yusibov V; Kushnir N; Streatfield SJ
Annu Rev Plant Biol; 2016 Apr; 67():669-701. PubMed ID: 26905655
[TBL] [Abstract][Full Text] [Related]
2. Plant Factories for the Production of Monoclonal Antibodies.
Sheshukova EV; Komarova TV; Dorokhov YL
Biochemistry (Mosc); 2016 Oct; 81(10):1118-1135. PubMed ID: 27908237
[TBL] [Abstract][Full Text] [Related]
3. [Plant-made pharmaceuticals].
Faye L; Lerouge P; Gomord V
Ann Pharm Fr; 2003 Mar; 61(2):109-18. PubMed ID: 12668949
[TBL] [Abstract][Full Text] [Related]
4. Viral vectors for production of recombinant proteins in plants.
Lico C; Chen Q; Santi L
J Cell Physiol; 2008 Aug; 216(2):366-77. PubMed ID: 18330886
[TBL] [Abstract][Full Text] [Related]
5. Current state-of-the-art in plant-based antibody production systems.
Donini M; Marusic C
Biotechnol Lett; 2019 Mar; 41(3):335-346. PubMed ID: 30684155
[TBL] [Abstract][Full Text] [Related]
6. Production of pharmaceutical-grade recombinant aprotinin and a monoclonal antibody product using plant-based transient expression systems.
Pogue GP; Vojdani F; Palmer KE; Hiatt E; Hume S; Phelps J; Long L; Bohorova N; Kim D; Pauly M; Velasco J; Whaley K; Zeitlin L; Garger SJ; White E; Bai Y; Haydon H; Bratcher B
Plant Biotechnol J; 2010 Jun; 8(5):638-54. PubMed ID: 20514694
[TBL] [Abstract][Full Text] [Related]
7. Production of antibodies in plants: approaches and perspectives.
Ko K; Brodzik R; Steplewski Z
Curr Top Microbiol Immunol; 2009; 332():55-78. PubMed ID: 19401821
[TBL] [Abstract][Full Text] [Related]
8. Plant-produced candidate countermeasures against emerging and reemerging infections and bioterror agents.
Streatfield SJ; Kushnir N; Yusibov V
Plant Biotechnol J; 2015 Oct; 13(8):1136-59. PubMed ID: 26387510
[TBL] [Abstract][Full Text] [Related]
9. Plant biopharming of monoclonal antibodies.
Ko K; Koprowski H
Virus Res; 2005 Jul; 111(1):93-100. PubMed ID: 15896408
[TBL] [Abstract][Full Text] [Related]
10. Photosynthetic biomanufacturing in green algae; production of recombinant proteins for industrial, nutritional, and medical uses.
Rasala BA; Mayfield SP
Photosynth Res; 2015 Mar; 123(3):227-39. PubMed ID: 24659086
[TBL] [Abstract][Full Text] [Related]
11. Plant-Derived Monoclonal Antibodies for Prevention and Treatment of Infectious Disease.
Hiatt A; Whaley KJ; Zeitlin L
Microbiol Spectr; 2014 Feb; 2(1):AID-0004-2012. PubMed ID: 26082108
[TBL] [Abstract][Full Text] [Related]
12. Plant virus expression vectors set the stage as production platforms for biopharmaceutical proteins.
Hefferon KL
Virology; 2012 Nov; 433(1):1-6. PubMed ID: 22979981
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of antibody production in plants for human therapeutic use.
Russell DA
Curr Top Microbiol Immunol; 1999; 240():119-38. PubMed ID: 10394718
[TBL] [Abstract][Full Text] [Related]
14. Plant-Produced Monoclonal Antibody as Immunotherapy for Cancer.
Nessa MU; Rahman MA; Kabir Y
Biomed Res Int; 2020; 2020():3038564. PubMed ID: 32908881
[TBL] [Abstract][Full Text] [Related]
15. Characterization of anti-CD20 monoclonal antibody produced by transgenic silkworms (Bombyx mori).
Tada M; Tatematsu K; Ishii-Watabe A; Harazono A; Takakura D; Hashii N; Sezutsu H; Kawasaki N
MAbs; 2015; 7(6):1138-50. PubMed ID: 26261057
[TBL] [Abstract][Full Text] [Related]
16. Role of plant expression systems in antibody production for passive immunization.
Virdi V; Depicker A
Int J Dev Biol; 2013; 57(6-8):587-93. PubMed ID: 24166441
[TBL] [Abstract][Full Text] [Related]
17. Glycosylation of Plant-Produced Immunoglobulins.
Göritzer K; Strasser R
Exp Suppl; 2021; 112():519-543. PubMed ID: 34687021
[TBL] [Abstract][Full Text] [Related]
18. From gene to harvest: insights into upstream process development for the GMP production of a monoclonal antibody in transgenic tobacco plants.
Sack M; Rademacher T; Spiegel H; Boes A; Hellwig S; Drossard J; Stoger E; Fischer R
Plant Biotechnol J; 2015 Oct; 13(8):1094-105. PubMed ID: 26214282
[TBL] [Abstract][Full Text] [Related]
19. Tobacco against Ebola virus disease.
Budzianowski J
Przegl Lek; 2015; 72(10):567-71. PubMed ID: 26946569
[TBL] [Abstract][Full Text] [Related]
20. Production systems for recombinant antibodies.
Schirrmann T; Al-Halabi L; Dübel S; Hust M
Front Biosci; 2008 May; 13():4576-94. PubMed ID: 18508530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
